content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <!-- Field: Pseudo-Tag; ID: Name; Data: OrbiMed Advisors Ltd -->
            <cik>0001491569</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001944885</issuerCik>
        <issuerName>Apollomics Inc.</issuerName>
        <secFileNumber>001-41670</secFileNumber>
        <issuerAddress>
          <com:street1>989 E. Hillsdale Blvd.</com:street1>
          <com:street2>Suite 220</com:street2>
          <com:city>Foster City</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94404</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>650-209-4055</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>OrbiMed Asia Partners, L.P.</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>Shareholder</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Class A Ordinary Shares</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Morgan Stanley</name>
          <address>
            <com:street1>1585 Broadway</com:street1>
            <com:city>New York</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10036</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>894807</noOfUnitsSold>
        <aggregateMarketValue>2863382.00</aggregateMarketValue>
        <noOfUnitsOutstanding>89480790</noOfUnitsOutstanding>
        <approxSaleDate>10/05/2023</approxSaleDate>
        <securitiesExchangeName>Nasdaq Stock Market</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Class A ordinary shares</securitiesClassTitle>
        <acquiredDate>03/29/2023</acquiredDate>
        <natureOfAcquisitionTransaction>Business combination</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>1810477</amountOfSecuritiesAcquired>
        <paymentDate>03/29/2023</paymentDate>
        <natureOfPayment>Cash</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <remarks>OrbiMed Asia GP, L.P. is the general partner of OrbiMed Asia Partners, L.P., and OrbiMed Advisors Limited is the genernal partner of OrbiMed Asia GP, L.P. OrbiMed Advisors LLC is the advisory company of OrbiMed Asia Partners, L.P.</remarks>
      <noticeSignature>
        <noticeDate>10/05/2023</noticeDate>
        <signature>/s/ Douglas Coon, Chief Compliance Officer, OrbiMed Advisors Limited, general partner of the general partner of OrbiMed Asia Partners, L.P.</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 3253}]
text: 144
  0001491569
  XXXXXXXX
  LIVE
  0001944885
  Apollomics Inc.
  001-41670
  989 E. Hillsdale Blvd.
  Suite 220
  Foster City
  CA
  94404
  650-209-4055
  OrbiMed Asia Partners, L.P.
  Shareholder
  Class A Ordinary Shares
  Morgan Stanley
  1585 Broadway
  New York
  NY
  10036
  894807
  2863382.00
  89480790
  10/05/2023
  Nasdaq Stock Market
  Class A ordinary shares
  03/29/2023
  Business combination
  Issuer
  N
  1810477
  03/29/2023
  Cash
  Y
  OrbiMed Asia GP, L.P. is the general partner of OrbiMed Asia Partners, L.P., and OrbiMed Advisors Limited is the genernal partner of OrbiMed Asia GP, L.P. OrbiMed Advisors LLC is the advisory company of OrbiMed Asia Partners, L.P.
  10/05/2023
  /s/ Douglas Coon, Chief Compliance Officer, OrbiMed Advisors Limited, general partner of the general partner of OrbiMed Asia Partners, L.P.